Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Rosko

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Geriatric Oncology|July 19, 2016
Survivorship care for older adults with cancer: U13 conference reportEmily J Guerard, Ginah Nightingale, Keith Bellizzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2022
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple MyelomaAbdullah M Khan, Filiz Yucebay, Qiuhong Zhao, et al.
Blood Neoplasia|September 15, 2025
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamabCharles Pei, Zeinab El Boghdadly, Lisa Blackburn, et al.
Plos One|May 8, 2024
E-PROOF: E-intervention for protein intake and resistance training to optimize function: A study protocolJessica L Krok-Schoen, Zachary L Chaplow, Cara Chase, et al.
Frontiers in Aging|June 24, 2024
The FITNESS study: longitudinal geriatric assessment, treatment toxicity, and biospecimen collection to assess functional disability among older adults with lung cancerMadison Grogan, Rebecca Hoyd, Jason Benedict, et al.
Cancers|May 14, 2022
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional ExperienceJordan Nunnelee, Francesca Cottini, Qiuhong Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 19, 2020
Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second LookJoseph E Maakaron, Christina Liscynesky, Zeinab El Boghdadly, et al.
Archives of Hematology and Blood Diseases|January 10, 2022
Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT)Akshata Pandit, Lai Wei, Luis Bustamante, et al.
Leukemia & Lymphoma|May 18, 2023
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m<sup>2</sup> versus 200mg/m<sup>2</sup> preparative regimens in patients with multiple myelomaNidhi Sharma, Evan Benson, Qiuhong Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 29, 2022
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution ExperienceAbdullah M Khan, Michael Ozga, Harshil Bhatt, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Geriatric Oncology|July 19, 2016
Survivorship care for older adults with cancer: U13 conference reportEmily J Guerard, Ginah Nightingale, Keith Bellizzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2022
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple MyelomaAbdullah M Khan, Filiz Yucebay, Qiuhong Zhao, et al.
Blood Neoplasia|September 15, 2025
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamabCharles Pei, Zeinab El Boghdadly, Lisa Blackburn, et al.
Plos One|May 8, 2024
E-PROOF: E-intervention for protein intake and resistance training to optimize function: A study protocolJessica L Krok-Schoen, Zachary L Chaplow, Cara Chase, et al.
Frontiers in Aging|June 24, 2024
The FITNESS study: longitudinal geriatric assessment, treatment toxicity, and biospecimen collection to assess functional disability among older adults with lung cancerMadison Grogan, Rebecca Hoyd, Jason Benedict, et al.
Cancers|May 14, 2022
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional ExperienceJordan Nunnelee, Francesca Cottini, Qiuhong Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 19, 2020
Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second LookJoseph E Maakaron, Christina Liscynesky, Zeinab El Boghdadly, et al.
Archives of Hematology and Blood Diseases|January 10, 2022
Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT)Akshata Pandit, Lai Wei, Luis Bustamante, et al.
Leukemia & Lymphoma|May 18, 2023
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m<sup>2</sup> versus 200mg/m<sup>2</sup> preparative regimens in patients with multiple myelomaNidhi Sharma, Evan Benson, Qiuhong Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 29, 2022
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution ExperienceAbdullah M Khan, Michael Ozga, Harshil Bhatt, et al.
Pageof 6